The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Glutamate-induced excitotoxicity in Parkinson's disease: The role of glial cells
Open accessAbstract
Glutamate is the major excitatory neurotransmitter in the central nervous system. Glutamate transmission efficiency depends on the correct functionality and expression of a plethora of receptors and transporters, located both on neurons and glial cells. Of note, glutamate reuptake by dedicated transporters prevents its accumulation at the synapse as well as non-physiological spillover. Indeed, extracellular glutamate increase causes aberrant synaptic signaling leading to neuronal excitotoxicity and death. Moreover, extrasynaptic glutamate diffusion is strongly associated with glia reaction and neuroinflammation. Glutamate-induced excitotoxicity is mainly linked to an impaired ability of glial cells to reuptake and respond to glutamate, then this is considered a common hallmark in many neurodegenerative diseases, including Parkinson's disease (PD). In this review, we discuss the function of astrocytes and microglia in glutamate homeostasis, focusing on how glial dysfunction causes glutamate-induced excitotoxicity leading to neurodegeneration in PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wu, D., Wang, S., Wen, X., Han, X., Wang, Y., Shen, M., Fan, S., Zhuang, J., Zhang, Z.-F., Shan, Q., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27577 · Cited by 26
RetractedSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Liddelow, S. A., & Barres, B. A. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.006 · Cited by 2,336
Zhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295 · cited 1×
“Transcriptomic data showing the expression of mouse (A) and human (B) genes in astrocytes, neurons, as well as microglia/macrophages.(176,177) Mouse and human astrocytes n 1⁄4 12 and n 1⁄4 6 cells, human and mouse neurons n 1⁄4 1 and n 1⁄4 2 cells, human and mouse microglia n 1⁄4 4 and n 1⁄4 2 cells.”
α-synuclein locus duplication as a cause of familial Parkinson's disease
Chartier-Harlin, M.-C., Kachergus, J., Roumier, C., Mouroux, V., Douay, X., Lincoln, S., Levecque, C., Larvor, L., Andrieux, J., Hulihan, M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17103-1 · Cited by 2,029
Neuroinflammation and M2 Microglia: The Good, the Bad, and the Inflamed
Cherry, J. D., Olschowka, J. A., & O’Banion, M. K. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-98 · Cited by 1,748
Verkhratsky, A., & Nedergaard, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00042.2016 · Cited by 1,678
McDonald, J. W., & Johnston, M. V. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90011-c · Cited by 1,416
Gliotransmitters Travel in Time and Space
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H. R., Robitaille, R., & Volterra, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.007 · Cited by 1,308
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson’s disease
Yun, S. P., Kam, T.-I., Panicker, N., Kim, S., Oh, Y., Park, J.-S., Kwon, S.-H., Park, Y. J., Karuppagounder, S. S., Park, H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0051-5 · Cited by 1,123
Innate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034
Cholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16390 · Cited by 989
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Glutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 979
Lewerenz, J., Hewett, S. J., Huang, Y., Lambros, M., Gout, P. W., Kalivas, P. W., Massie, A., Smolders, I., Methner, A., Pergande, M., et al. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4391 · Cited by 978
Cholesterol, lipid rafts, and disease
Simons, K., & Ehehalt, R. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0216390 · Cited by 916
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 841
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Lewerenz, J., & Maher, P. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00469 · Cited by 718
Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission
Pascual, O., Ben Achour, S., Rostaing, P., Triller, A., & Bessis, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111098109 · Cited by 693
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Neurotransmitter receptors on microglia
Pocock, J. M., & Kettenmann, H. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.007 · Cited by 650
Chhor, V., Le Charpentier, T., Lebon, S., Oré, M.-V., Celador, I. L., Josserand, J., Degos, V., Jacotot, E., Hagberg, H., Sävman, K., et al. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.02.005 · Cited by 647
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
Booth, H. D. E., Hirst, W. D., & Wade-Martins, R. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.001 · Cited by 633
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Inflammatory Response in the CNS: Friend or Foe?
Sochocka, M., Diniz, B. S., & Leszek, J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0297-1 · Cited by 573
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Physiology and pharmacology of striatal neurons
Kreitzer, A. C. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135422 · Cited by 530
The Indispensable Roles of Microglia and Astrocytes during Brain Development
Reemst, K., Noctor, S. C., Lucassen, P. J., & Hol, E. M. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00566 · Cited by 516
The 6-Hydroxydopamine model of parkinson’s disease
Simola, N., Morelli, M., & Carta, A. R. (2007) · Neurotoxicity Research · doi:10.1007/bf03033565 · Cited by 514
Axon degeneration in Parkinson's disease
Burke, R. E., & O'Malley, K. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.01.011 · Cited by 493
Pajarillo, E., Rizor, A., Lee, J., Aschner, M., & Lee, E. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.03.002 · Cited by 478
Braak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron
Skaper, S. D., Facci, L., Zusso, M., & Giusti, P. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00072 · Cited by 457
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
Hernandez, D. G., Reed, X., & Singleton, A. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13593 · Cited by 448
Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H., & Takahashi, H. (2000) · Acta Neuropathologica · doi:10.1007/pl00007400 · Cited by 441
Zou, J. Y., & Crews, F. T. (2005) · Brain Research · doi:10.1016/j.brainres.2004.11.014 · Cited by 410
Reactive astrocytes in neurodegenerative diseases
Li, K., Li, J., Zheng, J., & Qin, S. (2019) · Aging and disease · doi:10.14336/ad.2018.0720 · Cited by 398
Immune cell regulation of glia during CNS injury and disease
Greenhalgh, A. D., David, S., & Bennett, F. C. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0263-9 · Cited by 396
Kim, K., Lee, S., Kegelman, T. P., Su, Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 395
Neuroinflammation and regulation of glial glutamate uptake in neurological disorders
Tilleux, S., & Hermans, E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21325 · Cited by 381
Current and experimental treatments of Parkinson disease: A guide for neuroscientists
Oertel, W., & Schulz, J. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13750 · Cited by 369
Mechanisms of glutamate release from astrocytes
Malarkey, E. B., & Parpura, V. (2008) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.005 · Cited by 356
He, Y., Appel, S., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 348
Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate
Maezawa, I., & Jin, L.-W. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5966-09.2010 · Cited by 347
Gu, X.-L., Long, C.-X., Sun, L., Xie, C., Lin, X., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 340
Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis
Baj, A., Moro, E., Bistoletti, M., Orlandi, V., Crema, F., & Giaroni, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061482 · Cited by 331
Glutamate and Parkinson’s disease
Blandini, F., Porter, R. H. P., & Greenamyre, J. T. (1996) · Molecular Neurobiology · doi:10.1007/bf02740748 · Cited by 323
Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity
Kirkley, K. S., Popichak, K. A., Afzali, M. F., Legare, M. E., & Tjalkens, R. B. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0871-0 · Cited by 321
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
AMPA–Kainate Subtypes of Glutamate Receptor in Rat Cerebral Microglia
Noda, M., Nakanishi, H., Nabekura, J., & Akaike, N. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-01-00251.2000 · Cited by 318
Taylor, D. L., Jones, F., Kubota, E. S. F. C. S., & Pocock, J. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4456-04.2005 · Cited by 308
Greggio, E., Zambrano, I., Kaganovich, A., Beilina, A., Taymans, J.-M., Daniëls, V., Lewis, P., Jain, S., Ding, J., Syed, A., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708718200 · Cited by 308
Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice
Yue, M., Hinkle, K. M., Davies, P., Trushina, E., Fiesel, F. C., Christenson, T. A., Schroeder, A. S., Zhang, L., Bowles, E., Behrouz, B., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.031 · Cited by 281
Immune cells and CNS physiology: Microglia and beyond
Norris, G. T., & Kipnis, J. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20180199 · Cited by 274
Piani, D., & Fontana, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3578 · Cited by 274
Microglia, Amyloid, and Glucose Metabolism in Parkinson’s Disease with and without Dementia
Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., Walker, Z., Turkheimer, F. E., & Brooks, D. J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.255 · Cited by 274
Diógenes, M. J., Dias, R. B., Rombo, D. M., Vicente Miranda, H., Maiolino, F., Guerreiro, P., Näsström, T., Franquelim, H. G., Oliveira, L. M. A., Castanho, M. A. R. B., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0234-12.2012 · Cited by 271
Pisanu, A., Lecca, D., Mulas, G., Wardas, J., Simbula, G., Spiga, S., & Carta, A. R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.08.011 · Cited by 268
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Piccoli, G., Condliffe, S. B., Bauer, M., Giesert, F., Boldt, K., De Astis, S., Meixner, A., Sarioglu, H., Vogt-Weisenhorn, D. M., Wurst, W., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3730-10.2011 · Cited by 267
Klockgether, T., Turski, L., Honoré, T., Zhang, Z., Gash, D. M., Kurlan, R., & Greenamyre, J. T. (1991) · Annals of Neurology · doi:10.1002/ana.410300513 · Cited by 258
Furness, D. N., Dehnes, Y., Akhtar, A. Q., Rossi, D. J., Hamann, M., Grutle, N. J., Gundersen, V., Holmseth, S., Lehre, K. P., Ullensvang, K., et al. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.043 · Cited by 254
Role of Metabotropic Glutamate Receptors in Neurological Disorders
Crupi, R., Impellizzeri, D., & Cuzzocrea, S. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00020 · Cited by 252
Glutamate Receptors as Therapeutic Targets for Parkinsons Disease
Johnson, K., Conn, P., & Niswender, C. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709789824606 · Cited by 251
Genetic risk factors in Parkinson’s disease
Billingsley, K. J., Bandres-Ciga, S., Saez-Atienzar, S., & Singleton, A. B. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2817-y · Cited by 249
Nitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo‐Dukelow, M., Chaudhuri, A., Ciborowski, P., Cerny, R., Gelman, B., Thomas, M. P., Mosley, R. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244
Truban, D., Hou, X., Caulfield, T. R., Fiesel, F. C., & Springer, W. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160989 · Cited by 237
Chapter 36: Astrocytes and Parkinson's disease
Forno, L. S., DeLanney, L. E., Irwin, I., Monte, D. D., & Langston, J. W. (1992) · Progress in Brain Research · doi:10.1016/s0079-6123(08)61770-7 · Cited by 230
Astroglial Glutamate Signaling and Uptake in the Hippocampus
Rose, C. R., Felix, L., Zeug, A., Dietrich, D., Reiner, A., & Henneberger, C. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00451 · Cited by 229
Bernardino, L., Xapelli, S., Silva, A. P., Jakobsen, B., Poulsen, F. R., Oliveira, C. R., Vezzani, A., Malva, J. O., & Zimmer, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1510-05.2005 · Cited by 224
Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis
Pitt, D., Nagelmeier, I. E., Wilson, H. C., & Raine, C. S. (2003) · Neurology · doi:10.1212/01.wnl.0000090564.88719.37 · Cited by 222
Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion
Meshul, C. K., Emre, N., Nakamura, C. M., Allen, C., Donohue, M. K., & Buckman, J. F. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00189-4 · Cited by 209
Bridges, R., Lutgen, V., Lobner, D., & Baker, D. A. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003889 · Cited by 205
Impaired Inflammatory Responses in Murine Lrrk2-Knockdown Brain Microglia
Kim, B., Yang, M.-S., Choi, D., Kim, J.-H., Kim, H.-S., Seol, W., Choi, S., Jou, I., Kim, E.-Y., & Joe, E.-H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034693 · Cited by 203
Taylor, D. L., Diemel, L. T., & Pocock, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02150.2003 · Cited by 202
LRRK2 regulates synaptogenesis and dopamine receptor activation through modulation of PKA activity
Parisiadou, L., Yu, J., Sgobio, C., Xie, C., Liu, G., Sun, L., Gu, X.-L., Lin, X., Crowley, N. A., Lovinger, D. M., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3636 · Cited by 197
Goldwurm, S., Fonzo, A. D., Simons, E. J., Rohé, C. F., Zini, M., Canesi, M., Tesei, S., Zecchinelli, A., Antonini, A., Mariani, C., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.035568 · Cited by 195
Robinson, M. B., & Coyle, J. T. (1987) · The FASEB Journal · doi:10.1096/fasebj.1.6.2890549 · Cited by 193
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Troncoso-Escudero, P., Parra, A., Nassif, M., & Vidal, R. L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00860 · Cited by 191
Mitani, A., & Tanaka, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07176.2003 · Cited by 189
Extracellular glutamate: functional compartments operate in different concentration ranges
Moussawi, K., Riegel, A., Nair, S., & Kalivas, P. W. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00094 · Cited by 184
Byrnes, K. R., Stoica, B., Loane, D. J., Riccio, A., Davis, M. I., & Faden, A. I. (2009) · Glia · doi:10.1002/glia.20783 · Cited by 183
The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders
O’Donovan, S. M., Sullivan, C. R., & McCullumsmith, R. E. (2017) · npj Schizophrenia · doi:10.1038/s41537-017-0037-1 · Cited by 182
Patel, J. P., & Frey, B. N. (2015) · Neural Plasticity · doi:10.1155/2015/708306 · Cited by 177
Neuroimaging of Parkinson's disease: Expanding views
Weingarten, C. P., Sundman, M. H., Hickey, P., & Chen, N. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.007 · Cited by 175
DJ-1 in Parkinson’s Disease: Clinical Insights and Therapeutic Perspectives
Repici, M., & Giorgini, F. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091377 · Cited by 173
LRRK2 regulation of immune-pathways and inflammatory disease
Wallings, R. L., & Tansey, M. G. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180463 · Cited by 173
Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System
Malik, A. R., & Willnow, T. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225671 · Cited by 170
Current approaches to enhance glutamate transporter function and expression
Fontana, A. C. K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13200 · Cited by 168
Butchbach, M. E. R., Tian, G., Guo, H., & Lin, C.-L. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403938200 · Cited by 166
Prokineticin‐2 promotes chemotaxis and alternative A2 reactivity of astrocytes
Neal, M. P., Luo, J. D., Harischandra, D. S., Gordon, R., Sarkar, S., Jin, H., Anantharam, V., Désaubry, L., Kanthasamy, A. G., & Kanthasamy, A. (2018) · Glia · doi:10.1002/glia.23467 · Cited by 162
Astrocytes, Microglia, and Parkinson’s Disease
Joe, E.-H., Choi, D., An, J., Eun, J.-H., Jou, I., & Park, S.-M. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.2.77 · Cited by 159
Lecours, C., Bordeleau, M., Cantin, L., Parent, M., Paolo, T. D., & Tremblay, M. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00282 · Cited by 158
Self-citationTaylor, D. L., Diemel, L. T., Cuzner, M. L., & Pocock, J. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01062.x · Cited by 153
Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
Liu, C., Wang, X., Liu, C., & Zhang, H. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00514 · Cited by 149
Emerging Treatment Approaches for Parkinson’s Disease
Stoker, T. B., Torsney, K., & Barker, R. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00693 · Cited by 147
Steece‐Collier, K., Chambers, L. K., Jaw‐Tsai, S., Menniti, F. S., & Greenamyre, J. T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7374 · Cited by 141
van Landeghem, F. K. H., Stover, J. F., Bechmann, I., Brück, W., Unterberg, A. W., Bührer, C., & von Deimling, A. (2001) · Glia · doi:10.1002/glia.1082 · Cited by 140
Matikainen-Ankney, B. A., Kezunovic, N., Mesias, R. E., Tian, Y., Williams, F. M., Huntley, G. W., & Benson, D. L. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3314-15.2016 · Cited by 139
Zhang, H., & Sulzer, D. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-33-10585.2003 · Cited by 138
Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
Tuura, R., Baumann, C. R., & Baumann‐Vogel, H. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00806 · Cited by 135
Löschmann, P. A., Lange, K. W., Kunow, M., Rettig, K.-J., Jähnig, P., Honoré, T., Turski, L., Wachtel, H., Jenner, P. G., & MARSDEN, C. D. (1991) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02259538 · Cited by 134
Meredith, G. E., Totterdell, S., Beales, M., & Meshul, C. K. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.06.005 · Cited by 132
Gardoni, F., Boraso, M., Zianni, E., Corsini, E., Galli, C. L., Cattabeni, F., Marinovich, M., Luca, M. D., & Viviani, B. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-14 · Cited by 131
Graham, W. C., Robertson, R. G., Sambrook, M. A., & Crossman, A. R. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90376-3 · Cited by 126
Massie, A., Schallier, A., Kim, S. W., Fernando, R. N., Kobayashi, S., Beck, H., Bundel, D. D., Vermoesen, K., Bannai, S., Smolders, I. J., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-177212 · Cited by 126
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K. M., Tamagnan, G. D., Votaw, J. R., Wichmann, T., & Smith, Y. (2011) · Brain · doi:10.1093/brain/awr137 · Cited by 126
de Vries, H. E., Kooij, G., Frenkel, D., Georgopoulos, S., Monsonego, A., & Janigro, D. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03702.x · Cited by 125
Mesci, P., Zaïdi, S., Lobsiger, C. S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., & Boillée, S. (2014) · Brain · doi:10.1093/brain/awu312 · Cited by 119
Lofrumento, D. D., Saponaro, C., Cianciulli, A., Nuccio, F. D., Mitolo, V., Nicolardi, G., & Panaro, M. A. (2010) · NeuroImmunoModulation · doi:10.1159/000320027 · Cited by 118
Microglia trigger astrocyte-mediated neuroprotection via purinergic gliotransmission
Shinozaki, Y., Nomura, M., Iwatsuki, K., Moriyama, Y., Gachet, C., & Koizumi, S. (2014) · Scientific Reports · doi:10.1038/srep04329 · Cited by 113
Piccoli, G., Onofri, F., Cirnaru, M. D., Kaiser, C. J. O., Jagtap, P., Kastenmüller, A., Pischedda, F., Marte, A., von Zweydorf, F., Vogt, A., et al. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00914-13 · Cited by 113
LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase
Choi, I., Kim, B., Byun, J.-W., Baik, S. H., Huh, Y. H., Kim, J.-H., Mook-Jung, I., Song, W. K., Shin, J.-H., Seo, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9255 · Cited by 112
Civiero, L., Vancraenenbroeck, R., Belluzzi, E., Beilina, A. G., Lobbestael, E., Reyniers, L., Gao, F., Mičetić, I., Maeyer, M. D., Bubacco, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043472 · Cited by 112
Self-citationJones, C. K., Bubser, M., Thompson, A. D., Dickerson, J. W., Turle-Lorenzo, N., Amalric, M., Blobaum, A. L., Bridges, T. M., Morrison, R. D., Jadhav, S. B., et al. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187443 · Cited by 108
Volta, M., Beccano-Kelly, D. A., Paschall, S. A., Cataldi, S., MacIsaac, S. E., Kuhlmann, N., Kadgien, C. A., Tatarnikov, I., Fox, J., Khinda, J., et al. (2017) · eLife · doi:10.7554/elife.28377 · Cited by 108
Chung, E. K. Y., Chen, L. W., Chan, Y., & Yung, K. K. L. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21852 · Cited by 105
Serum amino acid profile in patients with Parkinson’s disease
Figura, M., Kuśmierska, K., Bucior, E., Szlufik, S., Koziorowski, D., Jamrozik, Z., & Janik, P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191670 · Cited by 101
Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases
Finsterwald, C., Magistretti, P. J., & Lengacher, S. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710144502 · Cited by 100
Beccano-Kelly, D. A., Kuhlmann, N., Tatarnikov, I., Volta, M., Munsie, L. N., Chou, P., Cao, L.-P., Han, H., Tapia, L., Farrer, M. J., et al. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00301 · Cited by 97
Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson’s disease model
Zhang, Y., He, X., Meng, X., Wu, X., Tong, H., Zhang, X., & Qu, S. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.454 · Cited by 97
Xiong, Y., Neifert, S., Karuppagounder, S. S., Liu, Q., Stankowski, J. N., Lee, B. D., Ko, H. S., Lee, Y., Grima, J. C., Mao, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712648115 · Cited by 97
The Therapeutic Role of Minocycline in Parkinson’s Disease
Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93
Sharma, A., Kazim, S. F., Larson, C. S., Ramakrishnan, A., Gray, J. D., McEwen, B. S., Rosenberg, P. A., Shen, L., & Pereira, A. C. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1903566116 · Cited by 92
Ren, L., Yi, J., Yang, J., Li, P., Cheng, X., & Mao, P. (2018) · Medicine · doi:10.1097/md.0000000000012172 · Cited by 92
Kim, J., Cha, S., Choi, Y. R., Jou, I., Joe, E.-H., & Park, S. M. (2016) · Scientific Reports · doi:10.1038/srep28823 · Cited by 87
Chotibut, T., Davis, R. W., Arnold, J. C., Frenchek, Z., Gurwara, S., Bondada, V., Geddes, J. W., & Salvatore, M. F. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8598-0 · Cited by 86
Jackman, N. A., Uliasz, T. F., Hewett, J. A., & Hewett, S. J. (2010) · Glia · doi:10.1002/glia.21050 · Cited by 86
MK801 suppresses the l-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats
Jonkers, N., Sarre, S., Ebinger, G., & Michotte, Y. M. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03147-x · Cited by 81
Chrétien, F. C., Decouvelaere, A., Bossuet, C., Rimaniol, A., Grand, R. L., Pavec, G. L., Créminon, C., Dormont, D., Gray, F., & Gras, G. S. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00426.x · Cited by 80
Hayashi, M. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041177 · Cited by 78
Increased plasma concentrations of aspartate, glutamate and glycine in Parkinson's disease
Iwasaki, Y., Ikeda, K., Shiojima, T., & Kinoshita, M. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90015-y · Cited by 76
Regulation of Glutamate Transport in Developing Rat Oligodendrocytes
DeSilva, T. M., Kabakov, A. Y., Goldhoff, P., Volpe, J. J., & Rosenberg, P. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.6129-08.2009 · Cited by 75
Blaylock, R. L. (2017) · Surgical Neurology International · doi:10.4103/sni.sni_441_16 · Cited by 71
Introduction to the glutamate–glutamine cycle
Sonnewald, U., & Schousboe, A. (2016) · Advances in Neurobiology · doi:10.1007/978-3-319-45096-4_1 · Cited by 69
Acute and subchronic MPTP administration differentially affects striatal glutamate synaptic function
Robinson, S., Freeman, P. A., Moore, C., Touchon, J. C., Krentz, L., & Meshul, C. K. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(02)00050-x · Cited by 69
Glutamate Receptors in Microglia
Murugan, M., Ling, E.-A., & Kaur, C. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660174 · Cited by 67
Microglial response to N-methyl-D-aspartate-mediated excitotoxicity in the immature rat brain
Acarín, L., Gonz�lez, B., Castellano, B., & Castro, A. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960408)367:3<361::aid-cne4>3.0.co;2-3 · Cited by 66
Ma, B., Xu, L., Pan, X., Sun, L., Ding, J., Xie, C., Koliatsos, V. E., & Cai, H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw194 · Cited by 66
Yang, H., Wang, L., Zang, C., Wang, Y., Shang, J., Zhang, Z., Liu, H., Bao, X., Wang, X., & Zhang, D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00045 · Cited by 66
Hsieh, M., Ho, S.-C., Yeh, K.-Y., Pawlak, C. R., Chang, H., Ho, Y., Lai, T.-J., & Wu, F.-Y. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.03.022 · Cited by 65
Microglial glutamate release evoked by α‐synuclein aggregates is prevented by dopamine
Pereira, M. D. S., Acuña, L., Hamadat, S., Rocca, J., González‐Lizárraga, F., Chehín, R. N., Sepulveda-Diaz, J. E., Bel, E. A. D., Raisman‐Vozari, R., & Michel, P. P. (2018) · Glia · doi:10.1002/glia.23472 · Cited by 63
Inhibition of Microglia Activation as a Phenotypic Assay in Early Drug Discovery
Figuera-Losada, M., Rojas, C. J., & Slusher, B. S. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113499406 · Cited by 60
Shen, H., Marino, R. A. M., McDevitt, R. A., Bi, G.-H., Chen, K., Madeo, G., Lee, P.-T., Liang, Y., De Biase, L. M., Su, T.-P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800886115 · Cited by 58
Vernon, A. C., Zbarsky, V., Datla, K. P., Croucher, M. J., & Dexter, D. T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04860.x · Cited by 55
Vallat‐Decouvelaere, A., Chrétien, F. C., Gras, G. S., Pavec, G. L., Dormont, D., & Gray, F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.475 · Cited by 55
Zhang, Y., Liu, Y., Kang, X.-P., Dou, C.-Y., Zhuo, R., Huang, S., Peng, L., & Wen, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.012 · Cited by 55
Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats
Massie, A., Schallier, A., Mertens, B., Vermoesen, K., Bannai, S., Sato, H., Smolders, I. J., & Michotte, Y. M. (2008) · Neuroreport · doi:10.1097/wnr.0b013e328312181c · Cited by 52
Neuroprotection by immunomodulatory agents in animal models of Parkinson’s disease
Peplow, P., & Martinez, B. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.237108 · Cited by 52
Zhang, Y., Meng, X., Jiao, Z., Liu, Y., Zhang, X., & Qu, S. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00609 · Cited by 52
New synaptic and molecular targets for neuroprotection in Parkinson's disease
Calabresi, P., Filippo, M. D., Gallina, A., Wang, Y., Stankowski, J. N., Picconi, B., Dawson, V. L., & Dawson, T. M. (2012) · Movement Disorders · doi:10.1002/mds.25096 · Cited by 50
Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice
Yao, K., & Zhao, Y. (2018) · Experimental Gerontology · doi:10.1016/j.exger.2018.07.010 · Cited by 49
Parkinson’s disease-linked Parkin mutations impair glutamatergic signaling in hippocampal neurons
Zhu, M. J., Cortese, G. P., & Waites, C. L. (2018) · BMC Biology · doi:10.1186/s12915-018-0567-7 · Cited by 44
Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum
Creed, R. B., Menalled, L., Casey, B. H., Dave, K. D., Janssens, H. B., Veinbergs, I., van der Hart, M., Rassoulpour, A., & Goldberg, M. S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.033 · Cited by 44
Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson’s Disease
Wu, X., Meng, X., Tan, F., Jiao, Z., Zhang, X., Tong, H., He, X., Luo, X., Xu, P., & Qu, S. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00683 · Cited by 41
Ceftriaxone Protects Astrocytes from MPP+ via Suppression of NF-ΚB/JNK/c-Jun Signaling
Zhang, Y., Zhang, X., & Qu, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8845-z · Cited by 39
Ponnazhagan, R., Harms, A. S., Thome, A. D., Jurkuvenaite, A., Gogliotti, R. G., Niswender, C. M., Conn, P. J., & Standaert, D. G. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9655-z · Cited by 37
Chrétien, F. C., Pavec, G. L., Decouvelaere, A., Marie-Bernadette-Delisle, Uro‐Coste, E., Ironside, J. W., Gambetti, P. L., Parchi, P., Créminon, C., Dormont, D., et al. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1058 · Cited by 36
Sid‐Otmane, L., Hamadjida, A., Nuara, S. G., Bédard, D., Gaudette, F., Gourdon, J. C., Michaud, V., Beaudry, F., Panisset, M., & Huot, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172957 · Cited by 34
Kelsey, J. E., Mague, S. D., Pijanowski, R., Harris, R., Kleckner, N. W., & Matthews, R. T. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1799-5 · Cited by 32
Stimulation of synaptoneurosome glutamate release by monomeric and fibrillated α‐synuclein
Sarafian, T. A., Littlejohn, K., Yuan, S. Y., Fernandez, C., Cilluffo, M. C., Koo, B., Whitelegge, J. P., & Watson, J. B. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24024 · Cited by 29
Tozzi, A., Durante, V., Bastioli, G., Mazzocchetti, P., Novello, S., Mechelli, A., Morari, M., Costa, C., Mancini, A., Filippo, M. D., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.008 · Cited by 27
Schildt, A., Walker, M. D., Dinelle, K., Miao, Q., Schulzer, M., OʼKusky, J. R., Farrer, M. J., Doudet, D. J., & Sossi, V. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181446 · Cited by 24
Elevation of feline interleukin 6-like activity in feline immunodeficiency virus infection
Ohashi, T., Goitsuka, R., WATARI, T., Tsujimoto, H., & Hasegawa, A. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90148-h · Cited by 23
Stayte, S., Laloli, K. J., Rentsch, P., Lowth, A., Li, K. M., Pickford, R., & Vissel, B. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113062 · Cited by 17
Tumor Necrosis Factor-Alpha Alters Electrophysiological Properties of Rabbit Hippocampal Neurons
Wang, D. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190043 · Cited by 7
DJ1 at the interface between neuro-degeneration and cancer
Meiser, J., Vázquez, A., & Hiller, K. (2017) · Oncotarget · doi:10.18632/oncotarget.14889 · Cited by 1
Cited by
Teleanu, R. I., Niculescu, A.-G., Roza, E., Vladâcenco, O., Grumezescu, A. M., & Teleanu, D. M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115954 · Cited by 596
Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
Brandebura, A. N., Paumier, A., Onur, T. S., & Allen, N. J. (2023) · Nature Reviews Neuroscience · doi:10.1038/s41583-022-00641-1 · Cited by 427
Striatal glutamatergic hyperactivity in Parkinson's disease
Campanelli, F., Natale, G., Marino, G., Ghiglieri, V., & Calabresi, P. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105697 · Cited by 86
Amin, R., Quispe, C., Docea, A. O., Ydyrys, A., Kulbayeva, M., Durna Daştan, S., Calina, D., & Sharifi-Rad, J. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105376 · Cited by 74
A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade
Granzotto, A., Canzoniero, L. M. T., & Sensi, S. L. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.600089 · Cited by 67
Metadata
- Authors
- Iovino, L., Tremblay, M. E., & Civiero, L.
- Venue
- Journal of Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 144
- Issue
- 3
- Pages
- 151-164
- ISSN
- 1347-8613 (ISSN-L)
- OpenAlex
- W3046860178
- Cited by
- 374
- References
- 176
- FWCI
- 15.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.